SJ
Sheela Jaiswal
About Sheela Jaiswal
Data last updated:
Sheela Jaiswal is a Director at Peter & Walse Medicaments Private Limited (since 2017). The company operates in Business Services. Peter & Walse Medicaments Private Limited reported revenue of ₹75.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Peter & Walse Medicaments Private Limited U74999BR2017PTC036111 | Director | 26 Oct 2017 | 2017 | ₹75.2 Lakh (FY 2025) | Active |
Board colleagues of Sheela Jaiswal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sahil Kumar | 09546674 | Peter & Walse Medicaments Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sheela Jaiswal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sheela Jaiswal
Sheela Jaiswal currently holds 1 directorship: Peter & Walse Medicaments Private Limited (Director, since 26 Oct 2017, revenue ₹75.2 Lakh (FY 2025)).
Sheela Jaiswal was first appointed on 26 Oct 2017 as Director at Peter & Walse Medicaments Private Limited.
The current boards of Sheela Jaiswal's companies include Sahil Kumar (Peter & Walse Medicaments Private Limited).